309
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Frequency and Predictors of Unsuppressed HIV Viral Load Among People with HIV in Nyaruguru District, Rwanda

, ORCID Icon, & ORCID Icon
Pages 381-395 | Received 24 May 2022, Accepted 29 Jul 2022, Published online: 12 Aug 2022

References

  • Joseph Davey D, Abrahams Z, Feinberg M, et al. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa. Int J STD AIDS. 2018;29:603–610. doi:10.1177/0956462417748859
  • World Health Organization. Global health sector strategy on HIV 2016–2021: towards ending AIDS. Available from: https://apps.who.int/iris/bitstream/handle/10665/246178/WHO-HIV-2016.05-eng.pdf. Accessed May 22, 2022.
  • Chipeta J, Schouten E, Aberle-grasse J. HIV prevalence and associated; 2009:225–241. Available from: https://dhsprogram.com/pubs/pdf/FR175/12Chapter12.pdf. Accessed August 2, 2022.
  • Cherutich C, Kurth A, Musyoki H, Kilonzo N, Maina W. HIV Self-testing in Sub-Saharan Africa: Strategies to Enhance and Measure Linkage to Care. Retrovirology. 2014;6:23. doi:10.4137/RRT.S12952
  • Williams BG, Korenromp EL, Gouws E, Dye C. The rate of decline of CD4 T-cells in people infected with HIV. arXiv preprint arXiv:0908.1556. 2009;4:3–4.
  • UNAIDS. The need for routine viral load testing: questions and answers; 2016:12.
  • Jackson-gibson M, Ezema AU, Orero W, et al. Facilitators and barriers to HIV pre- exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health;2021. 1–13. doi:10.1186/s12889-020-10013-y
  • Uganda Ministry of Health. Consolidated guidelines for Prevention and treatment of HIV. Kampala; 2016.
  • Minchella PA, Chipungu G, Kim AA, et al. Specimen origin, type and testing laboratory are linked to longer turnaround times for HIV viral load testing in Malawi. PLoS ONE. 2017;12(2):e0173009. doi:10.1371/journal.pone.0173009
  • Lehrer RI. Editorial Response: questions and answers about defensins. Clin Infect Dis. 1997;25(5):1141–1142. doi:10.1086/516082
  • Viral HIV, Monitoring L. Viral load toolkit an implementer ’ s guide to introducing; 2020.
  • Abdullah S, Ibrahim O, Okeji A, et al. Viral suppression among HIV-positive patients on antiretroviral therapy in northwestern Nigeria: an eleven-year review of tertiary care centre records, January 2009-December 2019. BMC Infect Dis. 2021;21:1031. doi:10.1186/s12879-021-06722-3
  • Waju B, Dube L, Ahmed M, Assefa SS. Unsuppressed viral load level in public health facilities: nonvirological predictors among adult antiretroviral therapy users in southwestern Ethiopia. HIV/AIDS - Res Palliat Care. 2021;13:513–526. doi:10.2147/HIV.S304653
  • Lecher SL, Fonjungo P, Ellenberger D, et al. HIV viral load monitoring among patients receiving antiretroviral therapy - eight Sub-Saharan Africa Countries, 2013–2018. MMWR Morb Mortal Wkly Rep. 2021;70(21):775–778. doi:10.15585/mmwr.mm7021a2
  • Stevens WS, Marshall TM. Challenges in implementing HIV load testing in South Africa. J Infect Dis. 2010;201(s1):S78–84. doi:10.1086/650383
  • Drain PK, Dorward J, Bender A, et al. Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV/AIDS response. Clin Microbiol Rev. 2019;32(3):e00097–e18. doi:10.1128/CMR.00097-18
  • Tran BX, Phuong N, Nguyen T. Patient satisfaction with HIV/AIDS care and treatment in the patient satisfaction with HIV/AIDS care and treatment in the decentralization of services delivery in Vietnam; 2012.
  • Chimbindi N, Bärnighausen T, Newell M. Patient satisfaction with HIV and TB treatment in a public programme in rural KwaZulu-Natal: evidence from patient-exit interviews. BMC Health Serv Res. 2014;14. doi:10.1186/1472-6963-14-32
  • Katz IT, Maughan-Brown B. Improved life expectancy of people living with HIV: who is left behind? Lancet HIV. 2017;4(8):e324–e326. doi:10.1016/S2352-3018(17)30086-3
  • Rangarajan S, Colby DJ, Giang LT, et al. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J virus Erad. 2016;2(2):94–101. doi:10.1016/S2055-6640(20)30466-0
  • Rodriguez-fernandez R, Id YL, Fransisca L, Id RR. HIV treatment outcomes following antiretroviral therapy initiation and monitoring: a workplace program in Papua, Indonesia HIV treatment outcomes following antiretroviral therapy initiation and monitoring: a workplace program in Papua, Indonesia. Plos One. 2019;14:e0212432.
  • Cherutich P, Kim AA, Kellogg TA, et al. Detectable HIV viral load in Kenya: data from a population-based survey. PLoS ONE. 2016;11(5):e0154318. doi:10.1371/journal.pone.0154318
  • Davey J. Factors associated with unsuppressed viral load in HIV-1 infected patients on 1st line antiretroviral therapy therapy in South Africa. South African AIDS Conf. 2017;29:603–610.
  • Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence to antiretroviral therapy among people living with HIV. North Am J Med Sci. 2013;5(3):220–223. doi:10.4103/1947-2714.109196
  • Chhim K, Mburu G, Tuot S, et al. Factors associated with viral non- suppression among adolescents living with HIV in Cambodia: a cross-sectional study. AIDS Res Ther;2018. 1–10. doi:10.1186/s12981-018-0188-9
  • International Epidemiology Databases to Evaluate AIDS (IEDEA). Report from the 12th International Conference on HIV Treatment, Pathogenesis and Prevention Research (INTEREST); 2018:1–39. Kigali, Rwanda. Available from http://interestworkshop.org/wp-content/uploads/2018/07/INTEREST-2018-Final-Report_10072018-1.pdf. August 5, 2022.
  • Rwanda Ministry of Health. Republic of Rwanda; Ministry of Health. Rwanda National HIV and viral hepatitis annual report; 2017-2018. Available from https://rbc.gov.rw/fileadmin/user_upload/report2019/report2019/Annual%20Report%20for%20HIV%20and%20Viral%20Hepatitis%202017-2018.pdf. Accessed August 5, 2022.
  • Mwumvaneza M, Hinda R, Nyankesha E, Mugwaneza P, Sebaziga G, Koleros A. HIV and AIDS in Rwanda, 2010 epidemiologic update. Change. 2010;2015:45.
  • El N, Head MPH. Xvii international aids conference. Aids. 2008;5:3–8.
  • Prevalence HI, Quintile HW. HIV prevalence: data from the 2010 Rwanda Demographic and Health Survey Demographic and Health Survey (RDHS). 2010. doi:10.1111/j.1756-185X.2010.01533.x
  • Collins JB, Verheyden CN, Mahabir RC. Core measures. Plast Reconstr Surg. 2013;131(6):1266–1271. doi:10.1097/PRS.0b013e31828bd17e
  • Rwanda Biomedical Center (RBC). Rwanda national HIV annual report 2015–2016. Rwanda Ministry of Health (RMOH); 2016:1–103. Available from: http://rbc.gov.rw/fileadmin/user_upload/report2019/report2019/Annual%20Report%20for%20HIV%202015-2016.pdf. Accessed January 12, 2022.
  • Negesa L. iMedPub Journals adherence to antiretroviral therapy and factors affecting among people living with HIV/AIDS and taking antiretroviral therapy, Dire Dawa Town, Eastern Ethiopia Abstract; 2017:1–6.
  • Davey DJ, Abrahams Z, Feinberg M, Prins M. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa. Int J STD AIDS. 2018;29:603–610.
  • Hicham T, Ilyas E, Tarik H, et al. Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco. Int J Mycobacteriol. 2019;8:113–117. doi:10.4103/ijmy.ijmy_41_19
  • Cherutich P, Kim AA, Kellogg TA, et al. Detectable HIV viral load in Kenya: data from a population-based survey. 2016;5:1–14.
  • Millum J, Wendler D, Emanuel EJ. Declaration of Helsinki and Protection for Vulnerable Research Participants—Reply. JAMA. 2014;311(12):1252–1253 doi: 10.1001/jama.2014.1281